“Our patients generally have a financial need or medical situations in which they must avoid public places or are too fragile to endure long waits at commercial airports…” One of the
Continue reading“Breast cancer patients over the age of 60 with early-stage, hormone-responsive small tumors who forego adjuvant endocrine, also called hormonal therapy, are not at an increased risk of mortality
Continue readingNews outlets have recently reported that new research shows the “anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women.”
Continue readingPMD (percent of mammographic density) is the percentage of breast density that shows up on a woman’s mammogram. It has long been known that dense breasts make it more difficult to get an accurate
Continue readingLymphedema is a common and frequently debilitating side effect of treatment for breast cancer. Studies have been limited and have not produced convincing evidence that various interventions are helpful.
Continue readingThe subject of cancer screening is very complex and H. Gilbert Welch's book, Should I Be Tested for Cancer: Maybe Not and Here's Why, does an excellent job of explaining thse complexities in
Continue readingI have have had little success in trying to determine if DCIS and LCIS are included in the mortality statistics for breast cancer. Below are links to breast cancer statistics reported by the American
Continue readingThe New York Times produced an interesting article by Nicholas Kristof, titled “Cancer from the Kitchen?” which touches on many of my concerns regarding environmental causes of cancer and breast
Continue reading